Pediatric neurofibromatosis 1 and parental stress: A multicenter study

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 141-146

  Esposito, Maria ^a   Marotta, Rosa ^b   Roccella, Michele ^c   Gallai, Beatrice ^d   Parisi, Lucia ^c   Lavano, Serena Marianna ^b   Carotenuto, Marco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Children; Maternal stress; Parental Stress Index; Von Recklingausen disease

Indexed keywords

ARTICLE; BODY MASS; CHILD; CHILD PARENT RELATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MATERNAL STRESS; MULTICENTER STUDY; NEUROFIBROMATOSIS; PARENTAL STRESS; PERCEPTION; PRESCHOOL CHILD; PREVALENCE; RATING SCALE; RELIABILITY; SCHOOL CHILD; VALIDITY;

EID: 84893492327     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S55518     Document Type: Article

References (69)

1. Sarnat HB, Flores-Sarnat L. Genetics of neural crest and neurocutaneous syndromes. Handb Clin Neurol. 2013;111:309-314.
2. OMIM. Online Mendelian Inheritance in Men. McKusick catalog of human genes. [webpage on the Internet]. Baltimore, MD: Johns Hopkins University Press; 2004. Available from: http://www.omim.org/entry/162200.
3. Hughes RA, Huson SM, editors. The Neurofibromatoses: A Pathogenetic and Clinical Overview. London: Chapman and Hall Medical; 1994.
4. Friedman JM, Gutmann DH, MacCollin MD, Riccardi VM, editors. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore, MD: Johns Hopkins University Press; 1999.
5. Upadhyaya M, Cooper DM, editors. Neurofibromatosis Type 1: From Genotype to Phenotype. Oxford: Bios Scientific; 1998.
6. Ashwal S, Rust R. Child neurology in the 20th century. Pediatr Res. 2003;53:345-361.
7. Ruggieri M. The different forms of neurofibromatosis. Childs Nerv Syst. 1999;15:295-308.
8. Hughes RA. Neurological complications of neurofibromatosis type 1. In: Hughes RA, Huson SM, editors. The Neurofibromatoses: A Pathogenetic and Clinical Overview. London: Chapman and Hall Medical; 1994:204-232.
9. Créange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological complications of neurofibromatosis type 1 in adulthood. Brain. 1999;122:473-481.
10. Carotenuto M, Esposito M. Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I. Neurol Sci. 2013;34(11):1905-1909.
11. Ablon J. Parents' responses to their child's diagnosis of neurofibromatosis 1. Am J Med Genet. 2000;93(2):136-142.
12. Glasscoe CA, Quittner AL. Psychological interventions for people with cystic fibrosis and their families. Cochrane Database Syst Rev. 2008:16;(3):CD003148.
13. Esposito M, Gallai B, Parisi L, et al. Maternal stress and childhood migraine: a new perspective on management. Neuropsychiatr Dis Treat. 2013;9:351-355.
14. Veale BM. Meeting the challenge of chronic illness in general practice. Med J Aust. 2003;179:247-249.
15. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care. 1998;12(4): 196-202.
16. Spieth LE, Stark LJ, Mitchell MJ, et al. Observational assessment of family functioning at mealtime in preschool children with cystic fibrosis. J Pediatr Psychol. 2001;26(4):215-224.
17. Carotenuto M, Esposito M, Di Pasquale F, De Stefano S, Santamaria F. Psychological, cognitive and maternal stress assessment in children with primary ciliary dyskinesia. World J Pediatr. 2013;9(4):312-317.
18. [No authors listed]. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1998;45:575-578.
19. Hachon C, Iannuzzi S, Chaix Y. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level. Brain Dev. 2011;33(1):52-61.
20. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278(1):51-57.
21. Esposito M, Verrotti A, Gimigliano F, et al. Motor coordination impairment and migraine in children: a new comorbidity? Eur J Pediatr. 2012;171(11):1599-1604.
22. Guzzetta A, Pizzardi A, Belmonti V, et al. Hand movements at 3 months predict later hemiplegia in term infants with neonatal cerebral infarction. Dev Med Child Neurol. 2010;52(8):767-772.
23. Guzzetta A, D'Acunto MG, Carotenuto M, et al. The effects of preterm infant massage on brain electrical activity. Dev Med Child Neurol. 2011;53 Suppl 4:46-51.
24. Esposito M, Gimigliano F, Ruberto M, et al. Psychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purpose. Neuropsychiatr Dis Treat. 2013;9:1433-1441.
25. Esposito M, Carotenuto M. Intellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioning. J Intellect Disabil Res. 2013. doi: 10.1111/jir.12036. In press.
26. Esposito M, Carotenuto M. Borderline intellectual functioning and sleep: the role of cyclic alternating pattern. Neurosci Lett. 2010;19;485(2):89-93.
27. Carotenuto M, Santoro N, Grandone A, et al. The insulin gene variable number of tandemrepeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity. J Endocrinol Invest. 2009;32(9): 752-755.
28. Carotenuto M, Bruni O, Santoro N, Del Giudice EM, Perrone L, Pascotto A. Waist circumference predicts the occurrence of sleep-disordered breathing in obese children and adolescents: a questionnaire-based study. Sleep Med. 2006;7(4):357-361.
29. Carotenuto M, Guidetti V, Ruju F, Galli F, Tagliente FR, Pascotto A. Headache disorders as risk factors for sleep disturbances in school aged children. J Headache Pain. 2005;6(4):268-270.
30. Esposito M, Parisi P, Miano S, Carotenuto M. Migraine and periodic limb movement disorders in sleep in children: a preliminary case-control study. J Headache Pain. 2013;14(1):57.
31. Carotenuto M, Gallai B, Parisi L, Roccella M, Esposito M. Acupressure therapy for insomnia in adolescents: a polysomnographic study. Neuropsychiatr Dis Treat. 2013;9:157-162.
32. Carotenuto M, Gimigliano F, Fiordelisi G, Ruberto M, Esposito M. Positional abnormalities during sleep in children affected by obstructive sleep apnea syndrome: The putative role of kinetic muscular chains. Med Hypotheses. 2013;81(2):306-308.
33. Carotenuto M, Esposito M, Parisi L, et al. Depressive symptoms and childhood sleep apnea syndrome. Neuropsychiatr Dis Treat. 2012;8: 369-373.
34. Carotenuto M, Esposito M, Pascotto A. Facial patterns and primary nocturnal enuresis in children. Sleep Breath. 2011;15(2):221-227.
35. Esposito M, Gallai B, Parisi L, et al. Primary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter study. Neuropsychiatr Dis Treat. 2013;9:437-443.
36. Esposito M, Carotenuto M, Roccella M. Primary nocturnal enuresis and learning disability. Minerva Pediatr. 2011;63(2):99-104.
37. Esposito M, Gallai B, Parisi L, et al. Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children. Neuropsychiatr Dis Treat. 2013;9:921-926.
38. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. 2004;45(9):1049-1053.
39. Coppola G, Licciardi F, Sciscio N, et al. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. Brain Dev. 2004;26(1):26-29.
40. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects [webpage on the Internet]. Ferney-Voltaire: World Medical Association; 1964 [amended 1975-2013]. Available from: http://www.wma.net/en/30publications/10policies/b3/. Accessed August 5, 2013.
41. Abidin RR. Parenting Stress Index, Third Edition: Professional Manual. Lutz, FL: Psychological Assessment Resources Inc; 1995.
42. Abdin RR. Parenting Stress Index-Short Form Manual. Los Angeles, CA: Western Psychological Services; 1990.
43. Carson DK, Schauer RW. Mothers of children with asthma: perceptions of parenting stress and the mother-child relationship. Psychol Rep. 1992;71:1139-1148.
44. Wysocki T, Huxtable K, Linscheid TR, Wayne W. Adjustment to diabetes mellitus in preschoolers and their mothers. Diabetes Care. 1989;12:524-529.
45. Cnossen MH, Moons KG, Garssen MP, et al. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 children, or =6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital. J Med Genet. 1998;35:624-627.
46. Banerjee S, Crouse NR, Emnett RJ, Gianino SM, Gutmann DH. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner. Proc Natl Acad Sci U S A. 2011;108(38):15996-16001.
47. Tada K, Kochi M, Saya H, et al. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1. Neuro Oncol. 2003;5(4):228-234.
48. Elia M, Amato C, Bottitta M, et al. An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy. Brain Dev. 2012;34(10):873-876.
49. Riccardi VM, Eichner JE, editors. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. London: Johns Hopkins University Press; 1986.
50. Violante IR, Ribeiro MJ, Cunha G, et al. Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network. PLoS One. 2012;7(6):e38785.
51. Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol. 2002;44:164-170.
52. Hyman SL, Arthur Shores E, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2006;48:973-977.
53. Friedman JM, Birch P, Greene C. National Neurofibromatosis Foundation International Database. Am J Med Genet. 1993;45:88-91.
54. North K. Neurofibromatosis type 1. Am J Med Genet. 2000;97: 119-127.
55. Levine TM, Materek A, Abel J, O'Donnell M, Cutting LE. Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol. 2006;13: 8-20.
56. Johnson H, Wiggs L, Stores G, Huson SM. Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Dev Med Child Neurol. 2005;47(4):237-242.
57. Reiter-Purtill J, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA, Noll RB. Parental distress, family functioning, and social support in families with and without a child with neurofibromatosis 1. J Pediatr Psychol. 2008;33(4):422-434.
58. Noll RB, Reiter-Purtill J, Moore BD, et al. Social, emotional, and behavioural functioning of children with NF1. Am J Med Genet A. 2007;143A(19):2261-2273.
59. Koinis-Mitchell D, McQuaid EL, Seifer R, et al. Symptom perception in children with asthma: cognitive and psychological factors. Health Psychol. 2009;28(2):226-237.
60. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291-2299.
61. Ievers CE, Drotar D. Family and parental functioning in cystic fibrosis. J Dev Behav Pediatr. 1996;17(1):48-55.
62. Walker LS, Ford MB, Donald WD. Cystic fibrosis and family stress: effects of age and severity of illness. Pediatrics. 1987;79(2):239-246.
63. Di Filippo T, Orlando MF, Concialdi G, et al. The quality of life in developing age children with celiac disease. Minerva Pediatr. 2013;65(6):599-608.
64. Hung JW, Wu YH, Yeh CH. Comparing stress levels of parents of children with cancer and parents of children with physical disabilities. Psychooncology. 2004;13:898-903.
65. Taanila A, Kokkonen J, Järvelin MR. The long-term effects of children's early-onset disability on marital relationships. Dev Med Child Neurol. 1996;38:567-577.
66. Quittner AL, Opipari LC, Espelage DL, Carter B, Eid N, Eigen H. Role strain in couples with and without a child with a chronic illness: associations with marital satisfaction, intimacy, and daily mood. Health Psychol. 1998;17:112-124.
67. Hodgkinson R, Lester H. Stresses and coping strategies of mothers living with a child with cystic fibrosis: implications for nursing professionals. J Adv Nurs. 2002;39(4):377-383.
68. Hullmann SE, Wolfe-Christensen C, Ryan JL, et al. Parental overprotection, perceived child vulnerability, and parenting stress: a cross-illness comparison. J Clin Psychol Med Settings. 2010;17(4): 357-365.
69. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178:1932-1939.